References
1. Bulletin of Rosstat of the Russian Federation for 2017, 2018 Calculation of RBC. (in Russian)
2. Claibornea D.T., Princea J.L., Scully E., et al. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4(+) T-cells, and disease progression. Proc Natl Acad Sci USA. 2015; 112 (12): E1480–9.
3. Lavreys L., Baeten J.M., Chohan V., et al. Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women. Clin Infect Dis. 2006; 42: 1333–9.
4. Dorrucci M., Rezza G., Vlahov D., et al. Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users. Italian Seroconversion Study. AIDS. 1995; 9: 597–604.
5. Espinoza L.R. Retrovirus-associated rheumatic syndromes. Eds by D.J. McCarty, W.J. Koopman. Arthritis and Allied Conditions. 13th ed. Philadelphia: Lea and Febiger, 2001: 2670–83.
6. Agababova E.R. Spondyloarthritis as an object of promising scientific research in rheumatology. Eds by Nasonova V.A., Bunchuk N.V. Selected lectures on clinical rheumatology. Moscow: Meditsina, 2001: 74–82. (in Russian)
7. Reveille J.D. The changing spectrum of rheumatic disease in human immunodefi ciency virus infection. Semin Arthritis Rheum. 2000; 30: 147–66.
8. Olive A., Salavert A., Manriquez M., Clotet B., Moragas A. Parotid lipomatosis in HIV positive patients: a new clinical disorder associated with protease inhibitors. Ann Rheum Dis. 1998; 57: 749.
9. Florence E., Schrooten W., Verdonck K., Dreezen C., Colebunders R. Rheumatological complications associated with the use of indinavir and other protease inhibitors. Ann Rheum Dis. 2002; 61: 82-4.
10. Maschan M.A., Novichkova G.A. Federal clinical guidelines for the diagnosis and treatment of hemophagocytic lymphohistiocytosis. Moscow, 2014: 19 p. (in Russian)
11. Henter J.-I. (chairman); Hemophagocytic Lymphohistiocytosis Study Group. HLH-2004. Treatment protocol of the Second International HLH Study 2004. Start of the Study: January 2004: 36 p.
12. Cascio A., Todaro G., Bonina L., Iaria C. Please, do not forget secondary hemophagocytic lymphohistiocytosis in HIV-infected patients. Int J Infect Dis. 2011; 15 (12): e885-6. DOI: https://doi.org/10.1016/j.ijid.2011.09.002
13. Nie Y., et al. Hemophagocytic lymphohistiocytosis in a patient with human immunodeficiency virus infection: a case report. Exp Ther Med. 2017; 13 (5): 2480-2.
14. Ramon I., et al. Recurrent haemophagocytic syndrome in an HIV-infected patient. Acta Clin Belg. 2010; 65 (4): 276-8.
15. Usman M., Thapa S.D., Hadid H., Yessayan L.T. HIV infection presenting proliferation of CD8+ T lymphocyte and hemophagocytic lym-phohistiocytosis. Int J STD AIDS. 2016; 27 (5): 411-3. DOI: https://doi.org/10.1177/0956462415585254
16. Manji F., Wilson E., Mahe E., Gill J., Conly J. Acute HIV infection presenting as hemophagocytic lymphohistiocytosis: case report and review of the literature. BMC Infect Dis. 2017; 17 (1): 633. DOI: https://doi.org/10.1186/s12879-017-2732-y
17. Park K.H., Yu H.S., Jung S.I., Shin D.H., Shin J.H. Acute human immunodeficiency virus syndrome presenting with hemophagocytic lymphohistiocytosis. Yonsei Med J. 2008; 49 (2): 325-8. DOI: https://doi.org/10.3349/ymj.2008.49.2.325
18. Stacey A.R., Norris P.J., Qin L., Haygreen E.A., Taylor E., Heitman J., et al. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type I infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol. 2009; 83 (8): 3719-33.